Member Info for clairesmith

The US Health is a massive beast of money, that is looking to improve profit margins and the "customer" process.

Read this to see how much better IQAI solution is: https://www.mayoclinic.org/tests-procedures/liver-biopsy/about/pac-20394576

The share price is still very cheap.
Ignore the idea of revenue currently, as this does not matter.
the whole point of this share is IP, patents, Accreditations, and Tech, and they have it all.

Look at the portfolio, Brain, Liver, Kidneys, and GAD Project. They are locking the market up.
I suspect the were going to sell SC, but then had an advisor or offer made and realised that doubling down for a few months will pay off big time.

As I have said on this share in previous posts, look at what IQAI are doing with their product portfolio, they are locking up the market with solid FDA / CE approved solutions, that is far better than a lot of current methods.

Add into this the GAD project, and the MCAP on this company globally is massive, in the hundreds of millions.

Realistically i could see Google offering to buy them for the £200M region to get all the patents and FDA approvals to roll into their AI Medical solutions. It would be cheap for Google and save them tons of time and resources.

The share price is still very cheap. Ignore the people talking about revenue etc... as this does not matter currently, the whole point of this share is IP, patents, Accreditations, and Tech, and they have it all.

this is fantastic news for IQAI and its shareholders.

As I previously said, they are locking up the market with patents and the new mass checking CT tech.

it will cost too much time and money for a lot of rivals to compete now, so IQAI have moved to the front of the race.

Add to this, when they get contracts in place for their whole suite, brain, kidney, liver checking, this will stop rivals getting contract footholds, and also mans IQAI can drop their prices for individual products but have so many across the range makes a unified profit.

a good guess based on the size of just the US market, this MCAP should be in the £150m range

looking at this company, their products, the change of the medical market, you can see they have played the best of moves, locking up the new growth market with patents and ready to roll out tech.

this company are now moving into a very exciting time that I can easily see fast adoption in the major medical spending economies.

the share is very very cheap, can see it being in the £1 region if everything goes right over the next year or so

generally I'm very excited about this company, the tech is great and a massive need for automation to drive mass medical checks.

would be nice to get some good news before the end of the year :)

alot of tree shaking and forcing auto sells today, balanced up by midday, this should gain position back tomorrow and the large funds buy up lots on the cheap for long term (6 months to a year) hold

there are only 2 major airplane engine makers, and this company has been around a long time.

the placing sucks in share dilution but is much-needed cash, we can't get away from that.

however, the drop by 60% at the opening was ridiculous but does mean for a lot of people a cheap buy-in price to hold for a few months and make a decent profit.

onwards and upwards! hopefully a great opening (110) tomorrow

put a pin in it until next year now, potential uptick before the end of year results, but starting to think the BoD are consolidating their position and getting projects in line to move north next year.

but if the tiktok ban kicks in, then hello Triller and 7Dig rise

the funds are out for blood, and this is a high profile share, so can see a bit of tree shaking happening the next couple of weeks and meaning consolidation. mid to end of November we will be turning the ship back to the 320 zones

from what the directors have said and other potential deals in the pipeline, do we think there will be another good RNS before the end of the year?

or is it best to stuff my shares in the draw and forget about them until 2022?

let me double down on this point.

@7Digital, how on earth is our company only worth £35m, if we have the key to the digital music kingdom, with massive social media companies all currently looking to lock down their audiences with better revenue capture techniques, and music rights be a big piece of the product/service.

honestly, @7digital BoD, are you just bad at your jobs, lazy, or liars? you have a product that is consumed by 99.9% of the western world (major record label music).

serious question, wondering if worth a morning punt?

for the company to run a share placing, raising £6.0 million (gross) through the placing of 266,666,667 new Ordinary Shares, at 2.25 pence per share, and then to be silent for an extended period is a very bad treatment of shareholders.

i'm in at 1.64, so at loss but not as bad as others, and also only have part of my portfolio in 7digital.

however I cant believe in this mass move to digital that 7Digital are not able to get some massive contracts in place, and really capitalise on the state of the world. If they cant deliver then none of the staff in 7digital top to bottom deserve to get hired and work at any other company. how much more of an open goal do they want?!?!?!

based on low MCAP. if they can snag a good enough global partner as they hinted to in the announcement of the stonechecker sale RNS then this would be into the 20's quick fast.

just hope the hold isn't longer than another year.

we need a RNS
I'm holdin' out for a RNS 'til the end of the night
Its gotta be strong
And its gotta be fast
And its gotta be full of profit might.
we need a RNS
I'm holdin' out for a RNS 'til the morning light
It's gotta be sure
And it's gotta be soon
And it's gotta be larger than life
Larger than life (ah ah)

this is not a five-minute company, the partnerships they build take some time, but generally when they announce a partnership that is usually a revenue stream due to the immediate nature of their business model.

would i like the price to be higher now, Yes!
can I wait a few weeks for the price to be potentially higher than what it was on the back of the Triller, BIG YES!

it was great RNS in that they decreased their cash burn, so they are now moving into longer-term revenue and profit mode, all fantastic

and more potential revenue in the music stream pipeline:

https://musically.com/2020/10/19/the-us-music-market-isnt-yet-at-peak-streaming-subscriptions/

From livestreaming platforms sharing their revenues with roadies, to immersive weekend-long gigs over high-end speakers, new music companies are innovating out of a crisis:

https://www.theguardian.com/music/2020/oct/19/streaming-startups-trying-to-save-music-industry-pandemic

https://www.phoneworld.com.pk/apple-launches-apple-music-tv-with-music-streaming/

would be great partnership